InvestorsHub Logo
icon url

antibluechip

11/09/18 5:27 PM

#156061 RE: sts66 #156036

sts66,

I forgot to say I have also been taking a little bit of statin. I say little because I cant take much and still function. But just 2mg keeps my LDL down there.

Who knows if I still have the original blockages. But I think I read somewhere that AMRN is involved in another research study called EVAPORATE IT,to test V on the Regression of Plaque. I wonder if they have another hunch about V. The regression of plaque would be the Holy Grail for AMRN.

Dave
icon url

ORBAPU

11/09/18 5:34 PM

#156064 RE: sts66 #156036

70% blockage is in effect narrowing of the artery and does not become a problem unless it gets fully blocked such as what can happen when plaque breaks off upstream. One of Vascepa's effects is plaque stabilization which may help prevent that. Lifestyle changes plus treatment with Vascepa likely can slow, stop, or regress narrowing of arteries. This is one reason I am expecting CVD death risk reduction to be reported tomorrow.

https://www.atherosclerosis-journal.com/article/S0021-9150(15)30055-1/pdf
icon url

VuBru

11/09/18 9:32 PM

#156145 RE: sts66 #156036

STS - Combined with statins, EPA causes plaque regression.